Customers

After a couple of years now we can see the results. Already a quarter of a century has passed and it is easy to understand and appreciate the road, which has been traveled, and where it is necessary to go to move further. The road to the top can be winding and difficult, but knowing the route, we can lead the rest. Through the experience of our achievements, we have gained the strength to expand, to move forward to new heights with the never-ending desire to become the absolute leader in the distribution of FMCG products in the CIS by providing our customers with high-quality products, perfect customer service, while acting in the best interests of our society, consumers, employees and shareholders. www.sns.ru

Valenta Pharm is a Russian innovative pharmaceutical company established in 1997 and focused on development and production of new original medicines. Valenta Pharm is engaged in development, production, and market launch of prescription and OTC medicines for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, urology, etc. The company's medicines portfolio comprises well-known brands as Ingavirin®, Grammidin®, Trimedat, Teraligen, Phenazepam, Pantocalcin®, Aminazin, etc. www.valentapharm.com

AKRIKHIN is one of the leading Russian pharmaceutical companies that produces effective, affordable and high quality medicines in the most popular therapeutic areas in Russia. The company is in the top 5 leading local pharmaceutical producers by sales on the Russian market*.

AKRIKHIN> celebrated its 80th anniversary in 2016. The company is actively developing, placing an emphasis on modernization and expanding production, as well as embracing new technologies. As a result, the company’s performance grows every year, in terms of both production output and sales volume. AKRIKHIN is also working on ambitious plans for the future.

www.akrikhin.com

BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.

www.biocadglobal.com